Human papillomavirus 16/18 E7-pulsed dendritic cell vaccination in stage IB-IIA cervical cancer patients: A phase I escalating dose trial
Santin AD, Bellone S, Palmieri M, Zanolini A, Ravaggi A, Siegel ER, Roman JJ, Burnett AF, Pecorelli S, Cannon M. Human papillomavirus 16/18 E7-pulsed dendritic cell vaccination in stage IB-IIA cervical cancer patients: A phase I escalating dose trial. J. Virol. 2008; 82:1968-1979.